2 beginner stocks to kick-start a portfolio

Edward Sheldon looks at two stocks that he believes could be ideal choices for those looking to start an investment portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Buying shares for the first time can be a daunting experience. However in my opinion, the key is to focus on putting together a portfolio of high quality companies that pay regular dividends with the intention of holding these companies for the long term and allowing compounding to work its magic. With that in mind, here’s two stocks I believe could be excellent choices for beginners.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) has excellent potential as a starter stock to my mind, as the world’s ageing population should provide significant tailwinds to the healthcare industry over the medium-to-long term and the healthcare giant looks well placed to benefit.

The company is currently undergoing a transition period, with management deciding to focus less on blockbuster drugs and more on vaccines and consumer health products. After an asset swap with Novartis in 2015, 45% of revenue now comes from selling products such as Beechams Cold & Flu and Sensodyne toothpaste, and the new business model should result in more stable and consistent revenues and cash flows.

GlaxoSmithKline’s dividend yield of 5.1% is one of the higher yields in the FTSE 100 and while there has been some concern in recent years as to whether this is sustainable, with earnings forecast to rise 40% and 10% for FY2016 and FY2017, the chances of a dividend cut are looking less likely to me.

After trading as high as 1727p in October last year, the shares have fallen 10% in the last few months to now trade at 1,560p and at this price, with a P/E ratio of a reasonable 15.4, they look good value. For those new to investing, I believe GlaxoSmithKline has strong potential as a core holding.

The City of London Investment Trust

The City of London Investment Trust (LSE: CTY) seems like another ideal beginner’s stock for the main reason that, although the trust trades like a regular share, it’s actually a portfolio of around 120 companies, thus offering fantastic diversification benefits and a low risk profile.

The trust’s objective is to provide long-term capital and income growth and it places a strong focus on rewarding shareholders with regular dividend payouts. The current yield is approximately 4% and incredibly, the dividend has been increased every year since 1966. 

Fund manager Job Curtis takes a cautious approach to investing, mainly going for equities on the London Stock Exchange, and the top five holdings include blue-chip names such as Royal Dutch Shell, British American Tobacco, HSBC, BP and Diageo. The trust is however allowed to invest in smaller FTSE 350 companies and therefore has access to companies with higher growth potential.

Bear in mind that as a portfolio of 120 stocks, it’s likely to rise and fall with market fluctuations and with market turbulence never too far away, there’s no guarantee that an investment in the City of London Investment Trust will be smooth sailing. However it has weathered many economic events and plenty of market turmoil through its conservative investment strategy, returning an annualised 12% per year over the last five years. As such I believe it’s an excellent choice for new investors looking to dip their toes into the market waters.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in GlaxoSmithKline, City of London Investment Trust, Royal Dutch Shell B and Diageo. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended BP, Diageo, HSBC Holdings, and Royal Dutch Shell B. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

Could the 9.8% M&G dividend yield get even bigger?

Christopher Ruane reckons that, although the M&G dividend yield is already close to a double-digit percentage, it could get better…

Read more »

Investing Articles

How much passive income could I earn by putting £380 a month into a Stocks and Shares ISA?

Christopher Ruane explains how he'd aim to turn a Stocks and Shares ISA into four-figure passive income streams each year.

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 passive income stocks I’m buying before an interest rate cut

With the market expecting interest rates to fall in August, time might be running out for investors looking to buy…

Read more »

Investing Articles

If I’d bought Rolls-Royce shares a year ago, here’s what I’d have now

Rolls-Royce shares have been the big FTSE 100 success story of the past 12 months and more. And there's still…

Read more »

Young female analyst working at her desk in the office
Investing Articles

If the Dow’s heading for 60,000 by 2030, can the FTSE 100 index hit 12,000?

Strategist Ed Yardeni predicts a 50% rise for America’s Dow Jones Industrial Average over six years. Can the FTSE 100…

Read more »

Investing Articles

Is the National Grid share price a once-in-a-decade opportunity?

The National Grid share price looks like a bargain. But there’s much more for investors to think about than a…

Read more »

Investing Articles

Here’s why the Rolls-Royce share price should keep gaining!

The Rolls-Royce share price is up 185% over the past 12 months, but there are a host of tailwinds that…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Buying 1,852 shares in this ultra-high yield FTSE 100 income stock would give me £1k a year

Harvey Jones is keen to load up on this blue-chip income stock that pays the highest yield on the FTSE…

Read more »